Dyne Therapeutics
Price & Volume
Stats
See moreOpen | $9.44 |
Previous Close | $9.91 |
Day Range | $9.07-$9.71 |
52W Range | $8.94-$47.45 |
Market Cap | $1.1B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.37 |
News
See moreYahoo Finance • 15 days ago
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer
Yahoo Finance • 15 days ago
Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer
Yahoo Finance • 19 days ago
Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months
Yahoo Finance • 24 days ago
Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum
About
CEO | Mr. John G. Cox M.B.A. |
Address | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 191 |
